빌리루빈 검사 시장 : 제품별, 기술별, 용도별, 환자별, 최종 용도별, 국가별, 지역별 - 세계 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Bilirubin Testing market size was valued at US$ 2,230.8 Million in 2025, expanding at a CAGR of 4.2% from 2026 to 2033.

A bilirubin laboratory test is a clinical chemistry test that helps measure levels of the orange-yellow bilirubin substance in the blood and provides a vital marker for jaundice, poor functioning of the liver, and the rate of breakdown of the red blood cells. The bilirubin test relies on the use of a venous blood sample mixed with the diazo reagent to conduct colorimetric analysis of the bilirubin. This is because the bilirubin is separated into conjugated bilirubin and unconjugated bilirubin, and their concentrations are measured using an analyzer. Thus, bilirubin testing enables accurate diagnosis, effective disease monitoring, and timely clinical decision-making.

Bilirubin Testing Market- Market Dynamics

Growing demand for early diagnosis to propel market demand

Growing demand for early diagnosis is driving the Bilirubin Testing market because awareness about neonatal jaundice is on the rise, incidences of liver diseases are high, and there is an increasing need for fast and reliable diagnostic tests in the hospitals and clinics. For instance, in 2026, according to the OECD, there is a need to have access to the cancer diagnosis at the earliest in order to satisfy the requirement for the early detection of cancer. The rate of early diagnosis of breast cancer was 56% and that of cervical cancer was 62%, while that of colorectal cancer was 22%. Clearly, there is a need for more effective screening procedures, faster and accurate diagnostic testing, and early treatment to ensure that the patients survive their diseases. Therefore, there will be an increased focus on early disease detection and hence drive the growth of bilirubin testing globally.

Bilirubin Testing Market- Segmentation Analysis:

The Global Bilirubin Testing market is segmented on the basis of Product, Technology, Application, Patient, End Use, and Region.

Among the given products, bilirubin reagent kits and assay consumables account for a prominent market share in the products that are listed, as these products are frequently utilized for the tests that are conducted regularly along with being vital for the determination of the bilirubin level in the test. In July 2025, Nova Biomedical launched its latest version of the BR2 Bilirubin Test Kit that has pre-packed assay consumables that aid in quick testing of total and direct bilirubin levels. Thus, use of bilirubin reagent kits is still widely supported.

Bilirubin Testing Market- Geographical Insights

North America holds notable share in the Bilirubin Testing market because of the presence of highly developed health care infrastructure, early screening of jaundice in newborns, and an increased number of cases of liver diseases. For instance, in 2026, according to the U.S. Centers for Disease Control and Prevention (CDC), chronic liver disease is an important health problem in the country; there are about 4.5 million US adults with liver disease, with 1.8% of the US population aged 18 years and above suffering from liver disease. There are 52,274 people in America dying due to chronic liver disease and cirrhosis, with a death rate of 15.4 deaths per 100,000 people; that makes chronic liver disease and cirrhosis the ninth leading cause of mortality in the United States. In this regard, the growing incidences of liver diseases have driven the adoption of advanced bilirubin testing kits.

France's industry of bilirubin testing is growing due to the modernization of hospitals' laboratories, the use of automated systems for clinical chemistry, and various healthcare programs related to prevention and treatment of diseases. For instance, in 2025, according to MedTech Europe, France will have one of the largest IVD markets in Europe and will be worth about (USD 2,400 million). The report indicates that the trend of modernization of hospital laboratories is caused by the extensive use of automated diagnostic systems, as well as using molecular diagnostics and digitalization of the workflow in clinical laboratories in order to accelerate the process of diagnosing in the health care system of the country. This investment is to speed up adoption of the latest solutions in bilirubin testing throughout France.

Bilirubin Testing Market- Competitive Landscape:

The Bilirubin Testing market comprises major players such as Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories, Inc. These companies have increased their market share through innovations in diagnostics and automation in laboratories and testing systems, as well as through their growing geographical presence and portfolio. In November 2025, Abbott Laboratories acquired Exact Sciences in order to integrate the diagnostics of Abbott, which include laboratory testing and precision diagnostics. The acquisition will help Abbott to integrate Exact Sciences in the laboratory test segment, which will add advanced clinical diagnostic capabilities to Abbott's capabilities. These strategic initiatives enhance diagnostic capabilities, accelerate innovation, and strengthen competitive positioning in the bilirubin testing market.

Recent Developments:

In March 2026, Siemens Healthineers AG (Frankfurt, Germany) launched the Atellica IM pTau217 and BDTau immunoassays as tests for research purposes. These are part of Siemens' Atellica IM portfolio that is now being expanded with next-generation biomarker assays, improving their integrated solution for clinical chemistry and immunoassay testing capabilities.

In January 2025, Thermo Fisher Scientific Inc. acquired the Purification & Filtration Division of Solventum under an acquisition that was valued at about $4.1 billion. The acquisition is expected to expand Thermo Fisher's product range which includes the analytical and clinical laboratory products for conducting diagnostics tests.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BILIRUBIN TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• DiaSys Diagnostic Systems GmbH
• HORIBA Ltd.
• ELITechGroup SAS
• QuidelOrtho Corporation
• Sysmex Corporation
• Mindray Bio-Medical Electronics Co., Ltd.
• DiaSorin S.p.A.
• Erba Mannheim
• Ortho Clinical Diagnostics, Inc.
• Others

GLOBAL BILIRUBIN TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

• Bilirubinometers (Transcutaneous & Blood-Based)
• Bilirubin Reagent Kits & Assay Consumables
• Test Cartridges & Strips
• Calibrators & Quality Controls
• Others

GLOBAL BILIRUBIN TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

• POC Testing
• Laboratory-Based Testing

GLOBAL BILIRUBIN TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

• Routine & Pre-operative Health Screening
• Hemolytic Disorders Assessment
• Liver Function Testing (LFT)
• Neonatal Jaundice Screening and Monitoring

GLOBAL BILIRUBIN TESTING MARKET, BY PATIENT- MARKET ANALYSIS, 2020 - 2033

• Adults
• Pediatric Patients
• Neonates

GLOBAL BILIRUBIN TESTING MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

• Maternity and Neonatal Clinics
• Diagnostic Laboratories
• Hospitals & NICUs
• Others

GLOBAL BILIRUBIN TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA

Table of Contents

1. Bilirubin Testing Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Bilirubin Testing Market Snippet by Product
  • 2.1.2. Bilirubin Testing Market Snippet by Technology
  • 2.1.3. Bilirubin Testing Market Snippet by Application
  • 2.1.4. Bilirubin Testing Market Snippet by Patient
  • 2.1.5. Bilirubin Testing Market Snippet by End Use
  • 2.1.6. Bilirubin Testing Market Snippet by Country
  • 2.1.7. Bilirubin Testing Market Snippet by Region
• 2.2. Competitive Insights

3. Bilirubin Testing Key Market Trends

• 3.1. Bilirubin Testing Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Bilirubin Testing Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Bilirubin Testing Market Opportunities
• 3.4. Bilirubin Testing Market Future Trends

4. Bilirubin Testing Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Bilirubin Testing Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Bilirubin Testing Market Landscape

• 6.1. Bilirubin Testing Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Bilirubin Testing Market - By Product

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
  • 7.1.2. Bilirubinometers (Transcutaneous & Blood-Based)
  • 7.1.3. Bilirubin Reagent Kits & Assay Consumables
  • 7.1.4. Test Cartridges & Strips
  • 7.1.5. Calibrators & Quality Controls
  • 7.1.6. Others

8. Bilirubin Testing Market - By Technology

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
  • 8.1.2. POC Testing
  • 8.1.3. Laboratory-Based Testing
  • 8.1.4. Others

9. Bilirubin Testing Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
  • 9.1.2. Routine & Pre-operative Health Screening
  • 9.1.3. Hemolytic Disorders Assessment
  • 9.1.4. Liver Function Testing (LFT)
  • 9.1.5. Neonatal Jaundice Screening and Monitoring
  • 9.1.6. Others

10. Bilirubin Testing Market - By Patient

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Patient, 2025 & 2033 (%)
  • 10.1.2. Adults
  • 10.1.3. Pediatric Patients
  • 10.1.4. Neonates

11. Bilirubin Testing Market - By End Use

• 11.1. Overview
  • 11.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
  • 11.1.2. Maternity and Neonatal Clinics
  • 11.1.3. Diagnostic Laboratories
  • 11.1.4. Hospitals & NICUs
  • 11.1.5. Others

12. Bilirubin Testing Market - By Geography

• 12.1. Introduction
  • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 12.2. North America
  • 12.2.1. Overview
  • 12.2.2. Bilirubin Testing Key Manufacturers in North America
  • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 12.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 12.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 12.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 12.2.7. North America Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
  • 12.2.8. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.2.9. U.S.
    • 12.2.9.1. Overview
    • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.2.9.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.9.6. U.S. Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.2.9.7. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.2.10. Canada
    • 12.2.10.1. Overview
    • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.2.10.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.2.10.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.10.6. Canada Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.2.10.7. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 12.3. Europe
  • 12.3.1. Overview
  • 12.3.2. Bilirubin Testing Key Manufacturers in Europe
  • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 12.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 12.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 12.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 12.3.7. Europe Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
  • 12.3.8. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3.9. Germany
    • 12.3.9.1. Overview
    • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.3.9.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.9.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.9.6. Germany Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.9.7. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3.10. UK
    • 12.3.10.1. Overview
    • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.3.10.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.10.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.10.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.10.6. UK Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.10.7. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3.11. France
    • 12.3.11.1. Overview
    • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.3.11.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.11.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.11.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.11.6. France Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.11.7. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3.12. Italy
    • 12.3.12.1. Overview
    • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.3.12.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.12.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.12.6. Italy Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.12.7. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3.13. Spain
    • 12.3.13.1. Overview
    • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.3.13.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.13.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.13.6. Spain Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.13.7. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3.14. The Netherlands
    • 12.3.14.1. Overview
    • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.14.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.14.6. The Netherlands Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.14.7. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3.15. Sweden
    • 12.3.15.1. Overview
    • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.3.15.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.15.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.15.6. Sweden Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.15.7. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3.16. Russia
    • 12.3.16.1. Overview
    • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.3.16.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.16.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.16.6. Russia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.16.7. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3.17. Poland
    • 12.3.17.1. Overview
    • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.17.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.17.6. Poland Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.17.7. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3.18. Denmark
    • 12.3.18.1. Overview
    • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.3.18.3. Denmark Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.18.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.18.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.18.6. Denmark Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.18.7. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3.19. Rest of Europe
    • 12.3.19.1. Overview
    • 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.3.19.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.19.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.19.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.19.6. Rest of the Europe Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.19.7. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 12.4. Asia Pacific (APAC)
  • 12.4.1. Overview
  • 12.4.2. Bilirubin Testing Key Manufacturers in Asia Pacific
  • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 12.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 12.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 12.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 12.4.7. APAC Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
  • 12.4.8. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4.9. China
    • 12.4.9.1. Overview
    • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.4.9.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.9.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.9.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.9.6. China Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.9.7. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4.10. India
    • 12.4.10.1. Overview
    • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.4.10.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.10.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.10.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.10.6. India Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.10.7. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4.11. Japan
    • 12.4.11.1. Overview
    • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.4.11.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.11.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.11.6. Japan Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.11.7. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4.12. South Korea
    • 12.4.12.1. Overview
    • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.12.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.12.6. South Korea Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.12.7. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4.13. Australia
    • 12.4.13.1. Overview
    • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.4.13.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.13.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.13.6. Australia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.13.7. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4.14. Indonesia
    • 12.4.14.1. Overview
    • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.4.14.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.14.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.14.6. Indonesia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.14.7. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4.15. Thailand
    • 12.4.15.1. Overview
    • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.4.15.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.15.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.15.6. Thailand Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.15.7. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4.16. Philippines
    • 12.4.16.1. Overview
    • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.16.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.16.6. Philippines Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.16.7. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4.17. Taiwan
    • 12.4.17.1. Overview
    • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.4.17.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.17.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.17.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.17.6. Taiwan Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.17.7. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4.18. Vietnam
    • 12.4.18.1. Overview
    • 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.4.18.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.18.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.18.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.18.6. Vietnam Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.18.7. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4.19. Rest of APAC
    • 12.4.19.1. Overview
    • 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.4.19.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.19.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.19.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.19.6. Rest of APAC Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.19.7. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 12.5. Latin America (LATAM)
  • 12.5.1. Overview
  • 12.5.2. Bilirubin Testing Key Manufacturers in Latin America
  • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 12.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 12.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 12.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 12.5.7. LATAM Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
  • 12.5.8. LATAM Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.5.9. Brazil
    • 12.5.9.1. Overview
    • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.9.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.9.6. Brazil Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.5.9.7. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.5.10. Mexico
    • 12.5.10.1. Overview
    • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.10.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.10.6. Mexico Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.5.10.7. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.5.11. Argentina
    • 12.5.11.1. Overview
    • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.11.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.11.6. Argentina Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.5.11.7. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.5.12. Colombia
    • 12.5.12.1. Overview
    • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.12.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.12.6. Colombia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.5.12.7. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.5.13. Rest of LATAM
    • 12.5.13.1. Overview
    • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 12.6. Middle East and Africa
  • 12.6.1. Overview
  • 12.6.2. Bilirubin Testing Key Manufacturers in Middle East and Africa
  • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 12.6.6. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 12.6.7. Middle East and Africa Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
  • 12.6.8. Middle East and Africa Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.6.9. Saudi Arabia
    • 12.6.9.1. Overview
    • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.6.10. United Arab Emirates
    • 12.6.10.1. Overview
    • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.6.11. Israel
    • 12.6.11.1. Overview
    • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.6.11.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.11.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.11.6. Israel Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.6.11.7. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.6.12. Turkey
    • 12.6.12.1. Overview
    • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.12.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.12.6. Turkey Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.6.12.7. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.6.13. Algeria
    • 12.6.13.1. Overview
    • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.13.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.13.6. Algeria Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.6.13.7. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.6.14. Egypt
    • 12.6.14.1. Overview
    • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.14.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.14.6. Egypt Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.6.14.7. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.6.15. Iran
    • 12.6.15.1. Overview
    • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.6.15.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.6.15.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.15.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.15.6. Iran Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.6.15.7. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.6.16. Qatar
    • 12.6.16.1. Overview
    • 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.6.16.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.6.16.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.16.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.16.6. Qatar Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.6.16.7. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.6.17. Rest of MEA
    • 12.6.17.1. Overview
    • 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 12.6.17.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.6.17.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.17.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.17.6. Rest of MEA Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.6.17.7. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Bilirubin Testing Industry

• 13.1. Competitive Benchmarking
  • 13.1.1. Competitive Dashboard
  • 13.1.2. Competitive Positioning
• 13.2. Company Profiles
  • 13.2.1. Abbott Laboratories
  • 13.2.2. F. Hoffmann-La Roche Ltd.
  • 13.2.3. Siemens Healthineers AG
  • 13.2.4. Thermo Fisher Scientific Inc.
  • 13.2.5. Bio-Rad Laboratories, Inc.
  • 13.2.6. bioMerieux SA
  • 13.2.7. DiaSys Diagnostic Systems GmbH
  • 13.2.8. HORIBA Ltd.
  • 13.2.9. ELITechGroup SAS
  • 13.2.10. QuidelOrtho Corporation
  • 13.2.11. Sysmex Corporation
  • 13.2.12. Mindray Bio-Medical Electronics Co., Ltd.
  • 13.2.13. DiaSorin S.p.A.
  • 13.2.14. Erba Mannheim
  • 13.2.15. Ortho Clinical Diagnostics, Inc.
  • 13.2.16. Others

14. 360 Degree AnalystView

15. Appendix

• 15.1. Research Methodology
• 15.2. References
• 15.3. Abbreviations
• 15.4. Disclaimer
• 15.5. Contact Us